Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.
De Salvo C, Wang XM, Pastorelli L, Mattioli B, Omenetti S, Buela KA, Chowdhry S, Garg RR, Goodman WA, Rodriguez-Palacios A, Smith DE, Abbott DW, Cominelli F, Bamias G, Xin W, Lee JJ, Vecchi M, Pizarro TT. De Salvo C, et al. Among authors: pastorelli l. Am J Pathol. 2016 Apr;186(4):885-98. doi: 10.1016/j.ajpath.2015.11.028. Epub 2016 Feb 22. Am J Pathol. 2016. PMID: 26908008 Free PMC article.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.
Bezzio C, Vernero M, Costa S, Armuzzi A, Fiorino G, Ardizzone S, Roselli J, Carparelli S, Orlando A, Caprioli FA, Castiglione F, Viganò C, Ribaldone DG, Zingone F, Monterubbianesi R, Imperatore N, Festa S, Daperno M, Scucchi L, Ferronato A, Pastorelli L, Alimenti E, Balestrieri P, Ricci C, Cappello M, Felice C, Coppini F, Alvisi P, Di Luna I, Gerardi V, Variola A, Mazzuoli S, Lenti MV, Saibeni S; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)’s COVID-19 Study Group. Bezzio C, et al. Among authors: pastorelli l. BMC Gastroenterol. 2023 Jul 5;23(1):230. doi: 10.1186/s12876-023-02841-0. BMC Gastroenterol. 2023. PMID: 37407913 Free PMC article.
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists.
Nardone OM, Marasco G, Lopetuso LR, Mocci G, Pastorelli L, Petruzzellis C, Scaldaferri F, On Behalf Of The Italian Association Of Young Gastroenterologist And Endoscopist Aggei. Nardone OM, et al. Among authors: pastorelli l. J Clin Med. 2023 Mar 2;12(5):2005. doi: 10.3390/jcm12052005. J Clin Med. 2023. PMID: 36902792 Free PMC article.
Do antibodies have a role in IBD pathogenesis?
Vecchi M, Spina L, Cavallaro F, Pastorelli L. Vecchi M, et al. Among authors: pastorelli l. Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S95-6. doi: 10.1002/ibd.20699. Inflamm Bowel Dis. 2008. PMID: 18816674 No abstract available.
Emerging drugs for the treatment of ulcerative colitis.
Pastorelli L, Pizarro TT, Cominelli F, Vecchi M. Pastorelli L, et al. Expert Opin Emerg Drugs. 2009 Sep;14(3):505-21. doi: 10.1517/14728210903146882. Expert Opin Emerg Drugs. 2009. PMID: 19656075 Free PMC article. Review.
103 results